Redcare Pharmacy Publishes Q3 2026 Earnings Call Transcript
Bitget2026/11/03 07:52- Redcare Pharmacy held its October 29, 2026, third-quarter earnings call with CEO Peter Schmid von Linstow and CFO Hendrik Krampe.
- Management reaffirmed full-year guidance, targeting positive free cash flow in 2027; cash flow will remain negative in 2026.
- German prescription revenue grew 56% in the third quarter; October growth slowed below 50%, in line with expectations.
- October nonprescription revenue growth is expected below 10%, reflecting a slow start to cough-and-cold sales.
- Third-quarter adjusted EBITDA margin rose 100 basis points to 3.4%; EBITDA reached EUR 12 million versus a EUR 2 million loss.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SoftBank develops contingency plans for slowdown in US data center business, considers shifting to other countries
A new twist has emerged in the US AI data center investment boom. SoftBank is preparing for cooling US demand and a deteriorating political environment, and does not rule out shifting data center construction priorities to other countries. As cross-border computing power delivery capability improves and investment returns come under question, the logic behind AI infrastructure expansion is loosening, and over $3.5 trillion in infrastructure investment now faces potential impairment risks.
Quantumrail Cancels 10 Billion Won Convertible Bond Offering
Crypto prices
More
